

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * drug catabolic process (GO:0042737) | 9.25103390 |
| 2 | negative regulation of fibrinolysis (GO:0051918) | 8.91559178 |
| 3 | regulation of fibrinolysis (GO:0051917) | 8.75816848 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 8.43484073 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 8.28734946 |
| 6 | glyoxylate metabolic process (GO:0046487) | 8.10792923 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 7.65606933 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.65606933 |
| 9 | fibrinolysis (GO:0042730) | 7.30093885 |
| 10 | cellular glucuronidation (GO:0052695) | 7.18026788 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.05892100 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 7.05892100 |
| 13 | urea metabolic process (GO:0019627) | 6.85946415 |
| 14 | uronic acid metabolic process (GO:0006063) | 6.83002343 |
| 15 | glucuronate metabolic process (GO:0019585) | 6.83002343 |
| 16 | regulation of protein activation cascade (GO:2000257) | 6.58706816 |
| 17 | ethanol oxidation (GO:0006069) | 6.52179941 |
| 18 | complement activation, alternative pathway (GO:0006957) | 6.52148033 |
| 19 | oxidative demethylation (GO:0070989) | 6.49745733 |
| 20 | bile acid biosynthetic process (GO:0006699) | 6.33587883 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 6.24549224 |
| 22 | regulation of complement activation (GO:0030449) | 6.11152459 |
| 23 | negative regulation of cholesterol transport (GO:0032375) | 6.06077904 |
| 24 | negative regulation of sterol transport (GO:0032372) | 6.06077904 |
| 25 | protein carboxylation (GO:0018214) | 6.05607133 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.05607133 |
| 27 | * drug metabolic process (GO:0017144) | 5.96581765 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 5.86197906 |
| 29 | blood coagulation, intrinsic pathway (GO:0007597) | 5.77306201 |
| 30 | bile acid metabolic process (GO:0008206) | 5.69841951 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.55894939 |
| 32 | urea cycle (GO:0000050) | 5.52459144 |
| 33 | regulation of plasminogen activation (GO:0010755) | 5.33710271 |
| 34 | glycine metabolic process (GO:0006544) | 5.31160287 |
| 35 | S-adenosylmethionine metabolic process (GO:0046500) | 5.28904033 |
| 36 | bile acid and bile salt transport (GO:0015721) | 5.28892697 |
| 37 | ethanol metabolic process (GO:0006067) | 5.28113552 |
| 38 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.21679451 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 5.21536113 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 5.18677067 |
| 41 | negative regulation of hemostasis (GO:1900047) | 5.18677067 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 5.15347049 |
| 43 | alkaloid metabolic process (GO:0009820) | 4.93033129 |
| 44 | negative regulation of coagulation (GO:0050819) | 4.71671618 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.68345904 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.68345904 |
| 47 | negative regulation of wound healing (GO:0061045) | 4.60600344 |
| 48 | phospholipid efflux (GO:0033700) | 4.55969594 |
| 49 | polyketide metabolic process (GO:0030638) | 4.52892553 |
| 50 | doxorubicin metabolic process (GO:0044598) | 4.52892553 |
| 51 | daunorubicin metabolic process (GO:0044597) | 4.52892553 |
| 52 | positive regulation of hemostasis (GO:1900048) | 4.39350879 |
| 53 | positive regulation of blood coagulation (GO:0030194) | 4.39350879 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35942169 |
| 55 | protein activation cascade (GO:0072376) | 4.33863832 |
| 56 | tyrosine metabolic process (GO:0006570) | 4.33227191 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 4.26723215 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 4.26723215 |
| 59 | tryptophan catabolic process (GO:0006569) | 4.26723215 |
| 60 | intestinal cholesterol absorption (GO:0030299) | 4.24921865 |
| 61 | heme transport (GO:0015886) | 4.23242237 |
| 62 | negative regulation of lipase activity (GO:0060192) | 4.16811258 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 4.11918950 |
| 64 | hormone catabolic process (GO:0042447) | 4.10151434 |
| 65 | response to mercury ion (GO:0046689) | 4.09156055 |
| 66 | positive regulation of coagulation (GO:0050820) | 4.06416943 |
| 67 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.03325684 |
| 68 | primary alcohol catabolic process (GO:0034310) | 4.02848783 |
| 69 | arginine metabolic process (GO:0006525) | 4.00463936 |
| 70 | acute-phase response (GO:0006953) | 3.98403536 |
| 71 | cholesterol efflux (GO:0033344) | 3.97948273 |
| 72 | high-density lipoprotein particle remodeling (GO:0034375) | 3.95949866 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.91297074 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.90286810 |
| 75 | complement activation (GO:0006956) | 3.89968285 |
| 76 | regulation of humoral immune response (GO:0002920) | 3.88296687 |
| 77 | L-methionine salvage (GO:0071267) | 3.88216771 |
| 78 | L-methionine biosynthetic process (GO:0071265) | 3.88216771 |
| 79 | amino acid salvage (GO:0043102) | 3.88216771 |
| 80 | complement activation, classical pathway (GO:0006958) | 3.85396303 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.84332412 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.84332412 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 3.84332412 |
| 84 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.83326652 |
| 85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.83297741 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.83297741 |
| 87 | aromatic amino acid family metabolic process (GO:0009072) | 3.80427298 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.79246172 |
| 89 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.78348565 |
| 90 | alpha-amino acid catabolic process (GO:1901606) | 3.75682407 |
| 91 | negative regulation of protein activation cascade (GO:2000258) | 3.72249872 |
| 92 | * xenobiotic metabolic process (GO:0006805) | 3.72089771 |
| 93 | steroid catabolic process (GO:0006706) | 3.71186204 |
| 94 | sodium-independent organic anion transport (GO:0043252) | 3.58946908 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 3.58854484 |
| 96 | regulation of lipoprotein particle clearance (GO:0010984) | 3.57663644 |
| 97 | tryptophan metabolic process (GO:0006568) | 3.53714210 |
| 98 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.52399175 |
| 99 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.52399175 |
| 100 | * exogenous drug catabolic process (GO:0042738) | 10.2570741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.09359301 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.77964585 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.97759116 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76169772 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19526257 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80826525 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.77899104 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.16286021 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.14121294 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.20336821 |
| 11 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.19084503 |
| 12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.11215412 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04974949 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.01947650 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2579518 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.65217191 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61482038 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47544928 |
| 19 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25862283 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21861056 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21321063 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20711637 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17005495 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12863689 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07912502 |
| 26 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05697088 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03520530 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01021877 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99207353 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98544360 |
| 31 | CBP_21632823_ChIP-Seq_H3396_Human | 0.97870733 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97427616 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95017254 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92516591 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91440291 |
| 36 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90970335 |
| 37 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89773794 |
| 38 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88605489 |
| 39 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88559461 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87503389 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87281577 |
| 42 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85847551 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82011766 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81266893 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.80629339 |
| 46 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.78097224 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77001126 |
| 48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76806937 |
| 49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76276979 |
| 50 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.76053729 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75717202 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71312574 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70943478 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.69738154 |
| 55 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68981663 |
| 56 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.66907599 |
| 57 | NFYA_21822215_ChIP-Seq_K562_Human | 0.65970708 |
| 58 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64966140 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63028860 |
| 60 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.62064451 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61741661 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61327652 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60835119 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60835119 |
| 65 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.59554332 |
| 66 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.57586104 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57561319 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57313896 |
| 69 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.56645579 |
| 70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.56130217 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.56061765 |
| 72 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.55933460 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.55693807 |
| 74 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55672343 |
| 75 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.55183117 |
| 76 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53865085 |
| 77 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.53847498 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.53827487 |
| 79 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.53754718 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.52937987 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.50317027 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.50170943 |
| 83 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.49396666 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.49236912 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.48497733 |
| 86 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48494543 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48160842 |
| 88 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.47959281 |
| 89 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.47862777 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.46995093 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46864652 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46638665 |
| 93 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.46623221 |
| 94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.46438749 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.46413497 |
| 96 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.46004476 |
| 97 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.44576922 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.44467509 |
| 99 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.44449096 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.44243821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005085_abnormal_gallbladder_physiolo | 6.31108116 |
| 2 | MP0005365_abnormal_bile_salt | 6.06450942 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 5.73754480 |
| 4 | MP0005360_urolithiasis | 5.61821513 |
| 5 | MP0003195_calcinosis | 4.93530797 |
| 6 | MP0003252_abnormal_bile_duct | 4.25954626 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.14616664 |
| 8 | MP0003868_abnormal_feces_composition | 3.44875874 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.43592976 |
| 10 | MP0009697_abnormal_copulation | 2.73859495 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.69809273 |
| 12 | MP0009840_abnormal_foam_cell | 2.54376801 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.34676889 |
| 14 | MP0005332_abnormal_amino_acid | 2.28003689 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.04489787 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 10.5426858 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.93930005 |
| 18 | MP0000609_abnormal_liver_physiology | 1.87353156 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.67312635 |
| 20 | MP0001764_abnormal_homeostasis | 1.52920356 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.30582754 |
| 22 | MP0009053_abnormal_anal_canal | 1.30462058 |
| 23 | MP0005408_hypopigmentation | 1.24206320 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.20889078 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.15870104 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.11792765 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07422918 |
| 28 | MP0001661_extended_life_span | 1.07157259 |
| 29 | MP0005451_abnormal_body_composition | 1.03746992 |
| 30 | MP0000598_abnormal_liver_morphology | 0.99885457 |
| 31 | MP0009643_abnormal_urine_homeostasis | 0.97581892 |
| 32 | MP0002132_abnormal_respiratory_system | 0.93000541 |
| 33 | MP0003186_abnormal_redox_activity | 0.87124694 |
| 34 | MP0005670_abnormal_white_adipose | 0.85785538 |
| 35 | MP0009763_increased_sensitivity_to | 0.83929151 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.81573025 |
| 37 | MP0008469_abnormal_protein_level | 0.80200405 |
| 38 | MP0005376_homeostasis/metabolism_phenot | 0.78949136 |
| 39 | MP0001915_intracranial_hemorrhage | 0.78756672 |
| 40 | MP0003011_delayed_dark_adaptation | 0.78361414 |
| 41 | MP0009764_decreased_sensitivity_to | 0.77417517 |
| 42 | MP0002971_abnormal_brown_adipose | 0.71402916 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.70980655 |
| 44 | MP0000604_amyloidosis | 0.70422953 |
| 45 | MP0005187_abnormal_penis_morphology | 0.69534793 |
| 46 | MP0003879_abnormal_hair_cell | 0.68102229 |
| 47 | MP0005395_other_phenotype | 0.67825528 |
| 48 | MP0005464_abnormal_platelet_physiology | 0.66864202 |
| 49 | MP0003690_abnormal_glial_cell | 0.66446225 |
| 50 | MP0003638_abnormal_response/metabolism_ | 0.63604004 |
| 51 | MP0002282_abnormal_trachea_morphology | 0.63561415 |
| 52 | MP0005535_abnormal_body_temperature | 0.62514239 |
| 53 | MP0005023_abnormal_wound_healing | 0.60933353 |
| 54 | MP0002168_other_aberrant_phenotype | 0.60362289 |
| 55 | MP0008874_decreased_physiological_sensi | 0.56113763 |
| 56 | MP0005266_abnormal_metabolism | 0.54837387 |
| 57 | MP0002249_abnormal_larynx_morphology | 0.54250432 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 0.53045183 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.52785776 |
| 60 | MP0008872_abnormal_physiological_respon | 0.52549948 |
| 61 | MP0005334_abnormal_fat_pad | 0.47468798 |
| 62 | MP0005164_abnormal_response_to | 0.41242216 |
| 63 | MP0004883_abnormal_blood_vessel | 0.40884699 |
| 64 | MP0000249_abnormal_blood_vessel | 0.40335616 |
| 65 | MP0005058_abnormal_lysosome_morphology | 0.39864867 |
| 66 | MP0009785_altered_susceptibility_to | 0.37669587 |
| 67 | MP0003718_maternal_effect | 0.36381104 |
| 68 | MP0000467_abnormal_esophagus_morphology | 0.35021398 |
| 69 | MP0009765_abnormal_xenobiotic_induced | 0.34727667 |
| 70 | MP0005647_abnormal_sex_gland | 0.34525212 |
| 71 | MP0003959_abnormal_lean_body | 0.34010524 |
| 72 | MP0003075_altered_response_to | 0.32679228 |
| 73 | MP0003329_amyloid_beta_deposits | 0.32393375 |
| 74 | MP0004130_abnormal_muscle_cell | 0.32378569 |
| 75 | MP0001851_eye_inflammation | 0.32101789 |
| 76 | MP0008873_increased_physiological_sensi | 0.31815652 |
| 77 | MP0005166_decreased_susceptibility_to | 0.30622670 |
| 78 | MP0005448_abnormal_energy_balance | 0.30575281 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.28196165 |
| 80 | MP0005197_abnormal_uvea_morphology | 0.26589446 |
| 81 | MP0004142_abnormal_muscle_tone | 0.23731935 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.22331644 |
| 83 | MP0003953_abnormal_hormone_level | 0.22121335 |
| 84 | MP0001881_abnormal_mammary_gland | 0.21584876 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.21120498 |
| 86 | MP0001756_abnormal_urination | 0.20602025 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.20273077 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.19966952 |
| 89 | MP0000566_synostosis | 0.19753820 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.18872130 |
| 91 | MP0002970_abnormal_white_adipose | 0.18805479 |
| 92 | MP0009115_abnormal_fat_cell | 0.18487239 |
| 93 | MP0003632_abnormal_nervous_system | 0.18392950 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.16804651 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.16411179 |
| 96 | MP0003436_decreased_susceptibility_to | 0.16315959 |
| 97 | MP0002928_abnormal_bile_duct | 0.16297221 |
| 98 | MP0000920_abnormal_myelination | 0.16268812 |
| 99 | MP0000858_altered_metastatic_potential | 0.15890136 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.14822484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 8.79496413 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.31340607 |
| 3 | Complement deficiency (HP:0004431) | 8.18507660 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 8.13826764 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 7.22759889 |
| 6 | Abnormality of complement system (HP:0005339) | 6.77118916 |
| 7 | Joint hemorrhage (HP:0005261) | 5.93236483 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.87249172 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.73756153 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.41351866 |
| 11 | Xanthomatosis (HP:0000991) | 4.80219860 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.71450310 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.66942813 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.60782380 |
| 15 | Glomerulonephritis (HP:0000099) | 4.44844556 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.02325400 |
| 17 | Spontaneous abortion (HP:0005268) | 4.00470803 |
| 18 | Fat malabsorption (HP:0002630) | 3.97906770 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.90112076 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.77968995 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.74109478 |
| 22 | Hyperglycinemia (HP:0002154) | 3.68402540 |
| 23 | Rickets (HP:0002748) | 3.63331181 |
| 24 | Nephritis (HP:0000123) | 3.63112393 |
| 25 | Steatorrhea (HP:0002570) | 3.46606981 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.39059130 |
| 27 | Hyperammonemia (HP:0001987) | 3.33504712 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.25268787 |
| 29 | Vascular calcification (HP:0004934) | 3.21211004 |
| 30 | Mitral stenosis (HP:0001718) | 3.16755015 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.05829463 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.05829463 |
| 33 | Hemorrhage of the eye (HP:0011885) | 3.04251871 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.02743309 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.00976848 |
| 36 | Hyperglycinuria (HP:0003108) | 2.92581586 |
| 37 | Gingival bleeding (HP:0000225) | 2.90332446 |
| 38 | Cardiovascular calcification (HP:0011915) | 2.85039236 |
| 39 | Osteomalacia (HP:0002749) | 2.84864695 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.81998475 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.76115961 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.65438975 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.61716237 |
| 44 | Epidermoid cyst (HP:0200040) | 2.57280425 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.57133007 |
| 46 | Purpura (HP:0000979) | 2.55018876 |
| 47 | Abnormality of vitamin metabolism (HP:0100508) | 2.50709588 |
| 48 | Bifid scrotum (HP:0000048) | 2.46799042 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.46321721 |
| 50 | Thrombophlebitis (HP:0004418) | 2.46300432 |
| 51 | Hyperphosphaturia (HP:0003109) | 2.42606148 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.40805051 |
| 53 | Pulmonary embolism (HP:0002204) | 2.35730114 |
| 54 | Glycosuria (HP:0003076) | 2.25851981 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.25851981 |
| 56 | Fair hair (HP:0002286) | 2.25395608 |
| 57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.20803162 |
| 58 | Metabolic acidosis (HP:0001942) | 2.20789924 |
| 59 | Menorrhagia (HP:0000132) | 2.16874192 |
| 60 | Neonatal hypoglycemia (HP:0001998) | 2.15268557 |
| 61 | Abnormality of the Achilles tendon (HP:0005109) | 2.13857980 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 2.13367298 |
| 63 | Irritability (HP:0000737) | 2.12507614 |
| 64 | Increased mean platelet volume (HP:0011877) | 2.06719082 |
| 65 | Arthropathy (HP:0003040) | 2.06538810 |
| 66 | Cholelithiasis (HP:0001081) | 2.04410191 |
| 67 | Myocardial infarction (HP:0001658) | 2.00619412 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.7338142 |
| 69 | Deep venous thrombosis (HP:0002625) | 10.1919158 |
| 70 | Hypophosphatemic rickets (HP:0004912) | 1.99470982 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 1.99169074 |
| 72 | Cholecystitis (HP:0001082) | 1.99169074 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 1.96619795 |
| 74 | Abnormal urine phosphate concentration (HP:0012599) | 1.93680422 |
| 75 | Elevated alkaline phosphatase (HP:0003155) | 1.93525433 |
| 76 | Poikilocytosis (HP:0004447) | 1.89488787 |
| 77 | Ketosis (HP:0001946) | 1.89259940 |
| 78 | Abnormal platelet volume (HP:0011876) | 1.87523642 |
| 79 | Joint swelling (HP:0001386) | 1.84808603 |
| 80 | Hypochromic anemia (HP:0001931) | 1.83233462 |
| 81 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82700464 |
| 82 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73540357 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 1.72571386 |
| 84 | Abnormal platelet function (HP:0011869) | 1.72443865 |
| 85 | Impaired platelet aggregation (HP:0003540) | 1.72443865 |
| 86 | Gangrene (HP:0100758) | 1.71829024 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 1.68758714 |
| 88 | Hydroxyprolinuria (HP:0003080) | 1.68758714 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 1.63793711 |
| 90 | Atrioventricular block (HP:0001678) | 1.62908043 |
| 91 | Increased serum ferritin (HP:0003281) | 1.62413888 |
| 92 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.60525031 |
| 93 | Abnormal biliary tract physiology (HP:0012439) | 1.60364476 |
| 94 | Bile duct proliferation (HP:0001408) | 1.60364476 |
| 95 | Reticulocytosis (HP:0001923) | 1.60092958 |
| 96 | Lethargy (HP:0001254) | 1.59923506 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.57613595 |
| 98 | Skin nodule (HP:0200036) | 1.56145246 |
| 99 | Alkalosis (HP:0001948) | 1.56122231 |
| 100 | Neonatal onset (HP:0003623) | 1.55836298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.94507390 |
| 2 | RIPK1 | 4.02629353 |
| 3 | PIK3CG | 3.39355465 |
| 4 | FGFR4 | 3.30369176 |
| 5 | TYK2 | 2.77128283 |
| 6 | MAP3K3 | 2.70809029 |
| 7 | PRPF4B | 2.61845065 |
| 8 | TRIB3 | 2.38355710 |
| 9 | MAP3K12 | 2.38030927 |
| 10 | IRAK3 | 2.33759937 |
| 11 | SIK1 | 2.27345090 |
| 12 | PRKACG | 2.14509821 |
| 13 | PIK3CA | 2.06104117 |
| 14 | NTRK3 | 2.05830590 |
| 15 | TBK1 | 1.90000898 |
| 16 | MST1R | 1.87039136 |
| 17 | BCKDK | 1.86769505 |
| 18 | NEK9 | 1.84761084 |
| 19 | ABL2 | 1.82579952 |
| 20 | EPHA3 | 1.71349993 |
| 21 | MAPK11 | 1.63281011 |
| 22 | MAP2K4 | 1.62167430 |
| 23 | PRKAA2 | 1.60683742 |
| 24 | MAP3K2 | 1.57308440 |
| 25 | FGFR3 | 1.57051910 |
| 26 | MYLK | 1.52023110 |
| 27 | IGF1R | 1.43513677 |
| 28 | PRKCG | 1.40012321 |
| 29 | PINK1 | 1.36947850 |
| 30 | JAK1 | 1.23928018 |
| 31 | PDPK1 | 1.18041804 |
| 32 | JAK2 | 1.08495198 |
| 33 | PRKCZ | 1.05396801 |
| 34 | ERBB2 | 1.04892262 |
| 35 | NLK | 1.03815643 |
| 36 | MAP3K1 | 1.01118602 |
| 37 | TAOK2 | 0.98636949 |
| 38 | MAP3K5 | 0.97728555 |
| 39 | TNK2 | 0.97632636 |
| 40 | MAPKAPK3 | 0.95361966 |
| 41 | MAP3K11 | 0.94095061 |
| 42 | KSR2 | 0.92132430 |
| 43 | EPHA4 | 0.92120529 |
| 44 | FER | 0.87170819 |
| 45 | ERBB4 | 0.82947933 |
| 46 | PRKACA | 0.80873660 |
| 47 | RET | 0.80652534 |
| 48 | EIF2AK1 | 0.80544161 |
| 49 | EPHB1 | 0.79335261 |
| 50 | PRKG1 | 0.79257939 |
| 51 | CDK6 | 0.78610089 |
| 52 | ZAP70 | 0.78049241 |
| 53 | BCR | 0.76145514 |
| 54 | SCYL2 | 0.76124576 |
| 55 | PRKAA1 | 0.75411881 |
| 56 | MAP2K3 | 0.73376472 |
| 57 | TAOK3 | 0.73275840 |
| 58 | PDK1 | 0.72967992 |
| 59 | PTK6 | 0.72785313 |
| 60 | MAP3K6 | 0.70880187 |
| 61 | CAMKK2 | 0.69486832 |
| 62 | DYRK1B | 0.65912275 |
| 63 | CSNK1D | 0.64106589 |
| 64 | MAP3K14 | 0.63804084 |
| 65 | STK16 | 0.62865998 |
| 66 | PRKCB | 0.61673903 |
| 67 | ICK | 0.61610642 |
| 68 | PRKCA | 0.60250150 |
| 69 | CSF1R | 0.59935576 |
| 70 | CAMK2G | 0.51973033 |
| 71 | SGK3 | 0.51601911 |
| 72 | RPS6KA3 | 0.51496912 |
| 73 | MAP3K13 | 0.50443198 |
| 74 | PIM2 | 0.49035801 |
| 75 | MAPK15 | 0.47051908 |
| 76 | MAPK4 | 0.46513639 |
| 77 | ARAF | 0.45218458 |
| 78 | SGK1 | 0.45151795 |
| 79 | INSRR | 0.43388428 |
| 80 | TGFBR2 | 0.43252000 |
| 81 | PKN2 | 0.43162634 |
| 82 | SRC | 0.42414728 |
| 83 | GSK3A | 0.41693076 |
| 84 | STK38 | 0.41326903 |
| 85 | DAPK2 | 0.40811000 |
| 86 | CSNK1E | 0.39614650 |
| 87 | MET | 0.39086740 |
| 88 | MAPK7 | 0.37134365 |
| 89 | EPHA2 | 0.34301171 |
| 90 | PRKACB | 0.32735119 |
| 91 | MTOR | 0.31684097 |
| 92 | CHUK | 0.30847678 |
| 93 | IKBKE | 0.30753561 |
| 94 | KDR | 0.30493559 |
| 95 | SGK223 | 0.30115779 |
| 96 | SGK494 | 0.30115779 |
| 97 | CAMK1D | 0.29442608 |
| 98 | CSNK1A1 | 0.29254764 |
| 99 | CSNK2A1 | 0.28010921 |
| 100 | SGK2 | 0.27789081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34163621 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.01683228 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.79171623 |
| 4 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.49620468 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.49605764 |
| 6 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.45411655 |
| 7 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.04291362 |
| 8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.02613356 |
| 9 | * Caffeine metabolism_Homo sapiens_hsa00232 | 2.95157629 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.91180655 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.85540376 |
| 12 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.74233783 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.70187447 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49108409 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.48904328 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.37887981 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.31076202 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20838870 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.20687092 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04524573 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.95660963 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.93664106 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.91577894 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77517016 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69391818 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62915984 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62568639 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.48669516 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41251737 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40381763 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40360186 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.37971084 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26944195 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25405630 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25053015 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18281525 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10643311 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10605147 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06177619 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01815933 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97561106 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94430050 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94119451 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90644666 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90021609 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88253206 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84577760 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 0.78884409 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76033716 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76011087 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.73476912 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72763067 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69021274 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63864750 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.63162987 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52943566 |
| 57 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42979561 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42156897 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40542494 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33810904 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31180827 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27826567 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24686621 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23727927 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.22676209 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20267906 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19650078 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16841484 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.14586419 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14239005 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.11626064 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.10532880 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03136735 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.02388437 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.01180531 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2688831 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2642222 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | -0.2573688 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2554587 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.2524045 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.2373102 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2233748 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2103687 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2062036 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1857526 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1852362 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1729978 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1435893 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1194972 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | -0.1183754 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1030398 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | -0.0890223 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0746629 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0677986 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0647907 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0447551 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0385172 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0214014 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0133135 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0097396 |

